The abstract is read at the publisher; the summary is JClub's.
A Virchow2+STAMP framework for 1,000 PRAME-tested melanocytic lesions achieved a test AUROC of 0.970 for slide-level malignancy classification.
- Why it matters: Interobserver variability limits reliable diagnosis of difficult melanocytic lesions, and foundation-model outputs are often hard to map onto established criteria and immunohistochemical markers.
- What they did: The model was trained on 800 cases and evaluated on a temporally held-out test set of 200, predicting malignancy and specific morphological criteria from H&E plus manual PRAME status.
- The result: Ulceration and dermal mitoses were predicted with AUROCs of 0.991 and 0.966, while PRAME from H&E alone was lower (AUROC 0.776–0.780), and PRAME score 4 vs 0 was linked to malignancy (adjusted OR 35.04, 95% CI 17.39–74.62).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.